A Year in Review: New Drugs and Drug News of 2021
01mar1:00 am2:00 amA Year in Review: New Drugs and Drug News of 2021
Event Details
While much of the industry’s attention in 2021 was focused on FDA decisions about COVID vaccines and related therapies, a total of 50 new drugs were approved in 2021, outpacing
Event Details
While much of the industry’s attention in 2021 was focused on FDA decisions about COVID vaccines and related therapies, a total of 50 new drugs were approved in 2021, outpacing the 10-year average for FDA drug approvals. This session provides a broad overview of the drugs approved in 2021, which includes significant growth in monoclonal antibody approvals. This session is designed to be a cursory overview of new approvals, bringing forward the most actionable and relevant pieces for those practicing in today’s pharmacies. The session includes a look at the COVID related emergency use authorizations and approvals introduced in 2021 and reviews some of the more controversial decisions and challenges of the year.
more
Time
(Tuesday) 1:00 am - 2:00 am(GMT-05:00) View in my time